Content about anastrozole

July 23, 2012
FDA approves Afinitor for advanced breast cancer

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new use for a Novartis cancer drug.

The drug maker said Friday that the FDA had approved Afinitor (everolimus) combined with exemestane for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer who have failed treatment with letrozole or anastrozole.

July 8, 2010
Roxane launches generic Amerge, Arimidex

Roxane Labs announced Thursday the launch of two new generic drugs....

COLUMBUS, Ohio Roxane Labs announced Thursday the launch of two new generic drugs.

 

The Columbus, Ohio-based generics subsidiary of German drug maker Boehringer Ingelheim, launched naratriptan tablets in the 1-mg and 2.5-mg strengths, and anastrozole tablets in the 1-mg strength.

 

 

June 30, 2010
AstraZeneca makes savings card for Arimidex users

Anglo-Swedish drug maker AstraZeneca has created a savings card for users of one of its...

June 28, 2010
Generic drug makers launch anastrozole tablets

The Food and Drug Administration has approved two new generic versions of a drug for...